Trial intelligence / Profile preview

Inflammatory response of bronchial cells to gastric juice from children on and off proton pump inhibitors

NL-OMON39158Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Jan 2013
Countries
1
01

Overview

Open-label trial in gastroesophageal reflux disease (GERD) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: IL-8 production in bronchial cell cultures exposed to gastric juice and Association between IL-8 production and gastric juice composition. Started Jan 2013; status: active, not recruiting.

02

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NL-OMON39158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON39158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call